Parkinson DiseasePostoperative Complicationsalpha-SynucleinAntiparkinson AgentsParkinsonian DisordersTreatment OutcomeParkinson Disease, SecondaryIntraoperative ComplicationsRetrospective StudiesLevodopaGlucosylceramidaseSubstantia NigraLewy BodiesDeep Brain StimulationFollow-Up StudiesMultiple System AtrophyTime FactorsDopamineDiabetes ComplicationsRisk Factors1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineProspective StudiesOxidopamineDopaminergic NeuronsSubthalamic NucleusPregnancy ComplicationsLewy Body DiseaseNeurodegenerative DiseasesGait Disorders, NeurologicMPTP PoisoningSupranuclear Palsy, ProgressivePostural BalanceReoperationSeverity of Illness IndexDance TherapyPutamenBrainUbiquitin-Protein LigasesEssential TremorIncidenceRisk AssessmentLength of StayNeuronsObstetric Labor ComplicationsGaucher DiseaseLaparoscopyPedunculopontine Tegmental NucleusPergolideSurgical Wound InfectionGaitREM Sleep Behavior DisorderCarbidopaCohort StudiesCase-Control StudiesOncogene ProteinsTyrosine 3-MonooxygenaseTomography, X-Ray ComputedEquipment FailureHemorrhageAge of OnsetHypokinesiaDisease Models, AnimalDevice RemovalNerve DegenerationGenetic Predisposition to DiseaseDrainageDementiabeta-SynucleinCorpus StriatumMutationForeign-Body MigrationMovement DisordersGlobus PallidusDyskinesiasSurgical Wound DehiscenceMesencephalonAge FactorsDeglutition DisordersPostoperative HemorrhageCatheters, IndwellingNeuroprotective AgentsHematomaManebMitochondriaPregnancyStentsAnastomosis, SurgicalCatheterizationBiliary Tract DiseasesDiabetic AngiopathiesIatrogenic DiseaseEndoscopyNervous System DiseasesNeuropsychological TestsPostoperative CareSuture TechniquesOlfaction DisordersFeasibility Studies1-Methyl-4-phenylpyridiniumSurgical Procedures, Minimally Invasive